Myogenic tone (MT) is a primary modulator of blood flow in the resistance vasculature of the brain, kidney, skeletal muscle, and perhaps other high-flow organs such as the pregnant uterus. MT is known to be regulated by endothelial-derived factors, including products of the nitric oxide synthase (NOS) and/or the cyclooxygenase (COX) pathways. We asked if pregnancy influenced MT in myometrial arteries (MA) and if so, whether such an effect could be attributed to alterations in NOS and/or COX. MA, 200-300 µm internal diameter, 2-3 mm length, were isolated from 10 nonpregnant and 12 pregnant women undergoing elective hysterectomy or cesarean section, respectively. In the absence of NOS and/or COX inhibition, pregnancy was associated with increased MT in endothelium-intact MA compared to MA from nonpregnant women (p<0.01). The increase in MT was not due to increased Ca 2+ entry via voltage-dependent channels since both groups of MA exhibited similar levels of constriction when exposed to 50mM KCl. NOS inhibition (L-NAME) or combined NOS/COX-inhibition (L-NAME/Indomethacin) increased MT in MA from pregnant women (p=0.001 and p=0.042, respectively) but was without effect in arteries from nonpregnant women. Indomethacin alone was without effect on MT in MA from either nonpregnant or pregnant women. We concluded that MT increases in MA during human pregnancy and that this effect was partially opposed by enhanced NOS activity.
Introduction
Human pregnancy is associated with significant cardiovascular changes to meet the metabolic demands of the placenta and fetus as well as the pregnant woman. Heart rate and stroke volume increase ~35% and ~15%, respectively, plasma volume expands ~40%, and unilateral uterine artery blood flow rises as much as 10-fold from ~34 ml/min in nonpregnant women to ~332 ml/min at term pregnancy (15; 16; 36) . These changes are accompanied by a pronounced reduction in maternal peripheral vascular resistance that results in a modest lowering of blood pressure near term in healthy pregnancies (5) . In spite of these dramatic changes in cardiovascular function, little is known in women about how pregnancy affects the intrauterine vasculature and, in particular, how it responds to changes in pressure and workload. A vessel of particular interest is the myometrial artery (MA) as it is a principal site of uterine vascular resistance and possibly endothelial dysfunction in pregnancies complicated by preeclampsia, and hence may contribute to the regulation of maternal uteroplacental blood flow (21; 33; 34) .
One mechanism by which the body regulates blood flow to end organs is by pressure-induced constriction, also known as myogenic tone (MT). MT was first described in the canine carotid artery by Bayliss in 1902 (4) and has been frequently observed in resistance-sized arteries (≤ 300µm) that exist in a partially constricted state from which they can constrict or dilate to meet the metabolic demands and/or perfusion requirements of their end organs. In the uterine circulation, MT has been observed in main uterine arteries in nonpregnant mice and second/third order uterine arteries from nonpregnant sheep, but this MT is attenuated as pregnancy progresses (51; 52) . In contrast, secondorder radial uterine arteries do not exhibit MT in nonpregnant rats, but MT is present as pregnancy progresses to term (11; 50) . To our knowledge, there are no studies of MT in uterine arteries from nonpregnant women, and most studies in pregnant women are limited by the use of a single physiologic intraluminal pressure (80 mmHg) (21) vs. the broad pressure range used in other species (11; 51; 52) . Therefore, the effect of pregnancy on MT in human uterine vessels is unclear.
Increased uteroplacental blood flow during pregnancy is associated with augmented endothelial-derived vasodilator production in experimental animals (11; 12; 18; 25; 47; 51) and women (8; 45; 49) , with much of the emphasis placed on the role of increased synthesis of endothelial-derived nitric oxide and/or its downstream signaling. Inhibitors of nitric oxide synthase (NOS) augment MT in uterine vessels from experimental animals (11;
13; 51) and in MA from pregnant women (19) (20) (21) , but less is known about the contribution of vascular cyclooxygenase (COX) products, which are also up-regulated in pregnancy (14; 19) . Furthermore, MA MT and its regulation by NOS and/or COX in nonpregnant women have yet to be studied.
The objectives of this study were to determine 1) whether pregnancy alters MT in human MA, and if so, 2) whether alterations in NOS/COX-signaling are involved. In order to assess MT across the full range of blood pressures, all experiments were performed at intraluminal pressures ranging from 10 to 100 mmHg.
Materials and Methods
All experimental protocols were performed in accordance with NIH guidelines for the use of human tissue and followed procedures approved by the Human Research Protection Program at Wake Forest University School of Medicine for obtaining informed consent.
Subjects. Twelve healthy pregnant women undergoing elective cesarean section and 10 nonpregnant women undergoing elective hysterectomy for benign disorders (see Table 1) were included in the present study. We excluded those women with pre-existing cardiovascular disease (e.g., hypertension, diabetes), a history of current smoking, and those with multiple births. The nonpregnant women included were: 1) premenopausal, 2) undergoing an elective hysterectomy for a benign disorder later confirmed by pathology report (i.e., fibroids, menorrhagia, uterine prolapsed, ovarian teratoma and/or uterine leiomyomata), and 3) without the above cardiovascular risk parameters. The primary anesthetics or analgesics used in the pregnant women were bupicicaine, fentanyl and duramorph. Patients undergoing hysterectomies received general anesthesia with isoflurane or desflurane.
Preparation of myometrial arteries. Full-thickness 1 cm wide x 1 cm deep biopsies were obtained at time of cesarean section from the upper lip of the uterine incision away from the placenta to prevent unwanted hemorrhage. Fundal placentation was observed in all participants. Tissue collection at time of hysterectomy was from the anterior portion of the uterus, which closely approximated the region collected from pregnant women. These methods for tissue collection were similar to those described by others (17; 19-21 All tissue samples were maintained in 4°C PSS and aerated with gas containing 21% O 2 , 74% N 2 and 5% CO 2 while dissecting MA segments from the outer third (maternal side) of the uterine biopsy in order to isolate similar sized vessels (200 to 300 µm internal diameter, 2 mm to 3 mm length). Arterial segments were transferred to a dissection chamber where they were allowed to equilibrate for 6 -8 h in oxygenated Krebs maintained at 3°C in order to approximate the same timing interval for all studies. All studies were completed within 24 h of receiving the tissue from the operating room. We observed no differences in the control pressure-response relationship in arteries studied in the first 12 h vs. the last 12 h following tissue collection (pregnant, p=0.356; nonpregnant, p=0.622). After equilibration, vessels were placed into the well of a 2 ml arteriograph (Instrumentation and Model Facility, University of Vermont, Burlington, VT) fitted with a borosilicate (FHC, Bowdoinham, ME) micropipette at both ends. Both the proximal and distal micropipettes were attached to 3-way Luer Stopcocks (Cole-Parmer, Vernon Hills, Illinois). The arteries were cannulated on the proximal pipette, secured with suture, gently flushed free of blood and then cannulated and secured on the distal pipette. The arteriograph containing the cannulated vessel was then transferred to the stage of an inverted microscope (Nikon) where the internal diameter of the artery was viewed, measured, and continuously recorded using video edge detection equipment and data acquisition software, respectively (IonOptix Inc., Milton, MA, USA). After placing the arteriograph on the microscope stage, the proximal cannula was attached to the pressure reservoir and the intraluminal pressure increased to 10 mmHg to allow a gentle continuous flushing of the intraluminal contents from the vessel for 2 min. The 3-way stopcock on the distal cannula was then closed in order to pressurize the artery; all experimental protocols were conducted under "no-flow" conditions. In all experiments, pressurized arteries were continuously superfused with PSS (8-10 mL/min) aerated with gas containing 21% O 2 , 74% N 2 and 5% CO 2 at 37°C.
Study protocol.
All experiments were conducted in a manner similar to that previously described (7) . Briefly, the cannulated arteries were initially pressurized to 20 mmHg and allowed to equilibrate for 20 min at 37°C. The intraluminal pressure was then increased to 60 mmHg for ~90 min during which the vessel was challenged with 50 mM KCl three times to confirm artery viability and assess maximal constriction, defined as smallest diameter recorded over a 2 min period in the presence of 50 mM KCl. Vessels that did not constrict to at least 30% of their passive diameter after exposure to 50 mM KCl were discarded. The constriction responses to 50 mM KCl, for the MA from nonpregnant and pregnant women are shown in Table 2 . Endothelial integrity was assessed in vessels using the endothelialdependent vasodilator, bradykinin (BK, 1 µM). Nonpregnant MA were pressurized at 60 mmHg and, due to the lack of MT, pre-constricted with phenylephrine (PE, 10-100 µM) prior to dilation with BK. MA from pregnant women also were pressurized at 60 mmHg and upon obtaining stable MT, challenged with BK to confirm endothelial function. PE-induced constriction and MT were similar in nonpregnant (n=3) and pregnant (n=5) MA, 40.4±6.0 % vs. 33.3±4.9 % maximal constriction (p=0.4, t-test), respectively. BK reversal of PEinduced tone in nonpregnant MA or MT-induced tone in pregnant MA did not differ (92.9±1.5 % vs. 87.8±3.8 % reversal of constriction, p=0.4 t-test respectively). After affirming smooth muscle viability, vessels were returned to Krebs and intraluminal pressure was set to 10 mmHg. The effects of pressure-induced vasoconstriction (MT) were studied by generating two sequential pressure curves for each arterial segment at pressure steps from 10 to 100 mmHg intraluminal pressure such that each artery segment acted as its own control (a series experimental design). After the first curve was generated, the tissues were allowed to recover for 10 min at 10 mmHg pressure. The vessels were then re-pressurized to 60mmHg (to confirm reproducible myogenic tone) and incubated for 30 min in either the non-specific NOS inhibitor N-omega-nitro-L-arginine methyl ester (L-NAME; 200 µmol/L), the non-specific COX inhibitor indomethacin (Indo; 10 µmol/L), or the two inhibitors together prior to starting the second pressure-diameter curve to determine the contribution of NOS-, COX-, or combined NOS/COX inhibition on MT in MA. Tissues were then returned to 10 mmHg, incubated in Ca 2+ -free PSS with a L-type Ca 2+ -channel inhibitor diltiazem (80 µmol/L) for 45 min, and, followed by a third pressure-diameter relationship to obtain fully dilated (passive) diameters. MT was expressed as a percent constriction of the passive diameter of the individual MA at the same intravascular pressure using the equation:
where DP is the "passive" diameter of the artery in Ca 2+ -free PSS with diltiazem and DA is the "active" diameter of the artery in response to the stimulus (change in intraluminal pressure) in Ca 2+ -containing PSS in the absence/presence of L-NAME, INDO or combined L-NAME/INDO. Statistical analyses. Data are expressed as the mean ± standard error of the mean (SEM). In instances where multiple segments from a single MA were used for a particular experimental protocol, the results from all experiments were averaged for a single "n", and hence, n-values reported in the figures and tables indicate numbers of subjects, not vessels.
Comparisons between pregnant and nonpregnant women for the continuous measures in Tables 1 and 2 and between two groups where indicated elsewhere were made using a two-sample ("Student's") t-test. Dichotomous measures were compared using Fisher's exact test. All p-values are based on two-sided comparisons. All analyses of MA MT were performed using analysis of variance (ANOVA) with repeated measures. The betweensubject factor was pregnancy status (yes, no) and the within-subject factors were treated as 12 repeated measures in a 2 x 6 doubly-repeated measures design for each woman's vessel,
given that MT was measured in MA on 12 times (i.e., at 6 different pressures and with or without the drug(s) of interest). An unstructured inhibitor-repeated factor and compoundsymmetry pressure-repeated factor model provided the best fit for these measures. All repeated measures analyses were performed using SAS PROC MIXED procedures (SAS, Carey, NC). Two approaches were used to test if the shape of the MT pressure curve differed by pregnancy or drug (LNAME, INDO, diltiazem) status. The first was a global test of interaction with pressure treated as a 6-category factor. Since this test has very low power to detect specific types of trends, a second approach was used in which pressure was treated as a continuous factor such that tests of interactions could determine if the first factor affected the general upward or downward trend in MT or a quadratic curvature in the plots. If there was a significant pressure (categorized) by inhibitor interaction, then pairwise comparisons between groups at individual pressures were analyzed using Bonferroni adjustment for post hoc multiple comparisons. Comparisons between groups were considered statistically significant when the p < 0.05. Asterices (*, **, ***) are placed above the symbols to designate comparisons that are significant at specific pressures and are located to the right of curves to designate significant overall main effects at p-values of < 0.05, 0.01, and 0.001 respectively.
Results
Subject characteristics. Nonpregnant women (n=10) ranged from 28-48 yrs of age and as a group were older than the pregnant women (n=12), who ranged from 21 to 42 yrs (Table   1 ). Eight of the 10 nonpregnant women fell within the same age range as the pregnant group (≤ 42 yrs). The groups did not differ in blood pressure, height, weight, body mass index (BMI), or parity. Nonpregnant women underwent elective hysterectomy for benign uterine complications (see methods). Women undergoing cesarean section fell within 3 groups: 10 of 12 were repeat cesarean section without complications, one underwent a repeat cesarean delivery due to shoulder dystocia, and the remaining was a first time cesarean delivery due to maternal Herpes infection.
MT in MA.
Representative responses to stepwise increases in intraluminal pressure from 10 to 100 mmHg in MA are illustrated in Figures 1A and 1B . Although the passive diameters were greater than active diameters in both nonpregnant and pregnant MA (P<0.001), those from pregnant women had smaller active diameters compared to nonpregnant ( Figure 1C and 1D, p<0.001). MT in pregnant MA was greater than in nonpregnant MA (overall p<0.001), with the effect of pregnancy on MT being dependent upon pressure (p<0.001) and the largest differences present at pressures ≥ 40 mmHg (p<0.001, Figure 2 ).
Comparisons within each group also showed that MT in pregnant MA at pressures ≥ 40 mmHg exceeded those observed at ≤ 20 mmHg (p<0.05); there were no effects of pressure in the nonpregnant group (Figure 2) .
KCl constriction. MT is closely linked to membrane depolarization, resulting in Ca 2+ entry via voltage-dependent Ca 2+ channels. Thus, our next series of experiments were designed to assess whether membrane depolarization using 50 mM KCl was different in MA from nonpregnant and pregnant women. Increasing extracellular KCl from 5 mM to 50 mM resulted in similar decreases in arterial diameter in arteries from both groups, indicating no differences in response to membrane depolarization ( Table 2) .
Contribution of NO to pressure-induced constriction.
To assess the role of nitric oxide (NO),
we compared the effects of NOS inhibition on MT in MA from nonpregnant and pregnant women. NOS inhibition with L-NAME (200 µM) did not affect MT in nonpregnant MA (p = 0.8, Figure 3A) . In pregnant women, MT rose with increasing pressure in a quadratic fashion, but MT was greater in the presence than the absence of L-NAME (p<0.001, Figure   3B ). Therefore, NOS inhibition augmented MT in pregnant arteries and acted in an additive manner to increase MT overall by 8.3 ± 3.2%. Figure 5A ).
Contribution of COX
In the pregnant women, MA showed a significant quadratic relationship with pressure (p<0.001, Figure 5B ), which was augmented 7.6±2.8% by the presence of combined L-NAME/INDO (p<0.04, Figure 5B ). The effect of combined LNAME/INDO did not differ from that observed by LNAME alone (7.6% vs. 8.3%, p=NS).
Discussion
Increasing evidence suggests that MT contributes to the regulatory mechanisms that control uteroplacental blood flow in pregnancy but the extent of this contribution remains unclear (6; 11; 13; 19; 50). To the best of our knowledge, this is the first study to examine and compare MT in MA from nonpregnant and pregnant women. We observed that arteries A major strength of our study was our ability to determine if pregnancy altered MT in relevant human uterine arteries, overcoming obstacles faced in studies using animal models (11; 13; 26; 51; 52). The distinctive nature of human pregnancy stemming from the nature of human trophoblast invasion, vascular remodeling, placental architecture and bipedal posture argues in favor of studying human rather than experimental animal tissues.
We studied MA from the outer third of the uterine wall in pregnant women so as to be sampling from the same vascular region and to be studying similarly-sized arteries in the nonpregnant and pregnant groups. In addition, we assessed alterations in MT across the full range of pressures (10 to 100 mmHg) in order to encompass both normal and pathophysiologic pressures, and examined the contributions of NOS and COX in a similar manner using well-established inhibitors separately and in combination. Although the nonpregnant group was nine yrs older than the pregnant women, the age range was similar in the two groups and eight of the 10 nonpregnant women were within the same age range.
The uterine vascular bed is progressively remodeled throughout pregnancy in all species (see review by Osol and Mandala (35)), which results in a redistribution of blood flow within the pregnant uterus from the myoendometrial tissues to the uteroplacental vascular bed (i.e., spiral arterioles, intervillous space) (5; 15; 16; 36) . Although the spiral arterioles contribute to the regulation of uteroplacental perfusion (27; 31; 37; 38), they are difficult to obtain and study and undergo remodeling that, by definition, is not present in nonpregnant vessels. Therefore, we studied MA of similar size from nonpregnant and pregnant women. We consider that these arteries may play one or more of three roles: 1)
be responsible for myoendometrial blood flow, 2) be partially responsible for blood flow through the distal spiral arterioles, and/or 3) representative of the downstream spiral arterioles. It is unclear which is correct but any or all of these possibilities is (are) likely to contribute to the regulation of uteroplacental blood flow. Furthermore, MT is evident in pregnant MA across the full range of pressures (10 to 100 mmHg), which encompasses normal and pathologic perfusion pressures, thus extending the observations of Kublickiene et al (20) , who focused on flow-dependent dilation in human MA and in that report, MT was therefore studied only at a single intraluminal pressure following norepinephrine preconstruction as required to assess flow-dependent dilation (19; 21; 22) .
Although MT has been observed in MA from pregnant women (19-22; 48) and various generations of nonpregnant and pregnant UA from other species (11; 51; 52), it is unclear how MT is affected by human pregnancy (19) (20) (21) (22) . To the best of our knowledge, this is the first comparison of MT in nonpregnant and pregnant human MA. The observation that pregnancy raises MT in MA is somewhat unexpected, given the increased production of endothelial-dependent vasodilators (8; 11; 12; 19) that would be expected to decrease or attenuate MT. Furthermore, the shape of our pressure-response curves in pregnant MA differed from that observed by Kublickiene et al (20) in a study in which MT was examined across a 20 -120 mmHg pressure range. That study found that MT was greatest at lower intraluminal pressures (i.e., 20 mmHg) and decreased modestly as pressures rose to 100 mmHg) (20) , whereas our study found that MT increased from 10 to 60 mmHg and tapered off as pressures approached 100 mmHg. The reasons for the differences in the shape of the pressure dose-response curve are unclear. One possibility is that Kublickiene et al (20) used a HEPES-based buffer while we used a non-HEPES buffer (PSS), since differences in vascular reactivity with different kinds of buffering solutions have been observed (1) . A second reason may be the greater diameter of the MA studied by Kublickiene; for example at 20 mmHg, the vessels in that study averaged 295±27 µm whereas those in the present study averaged 229±14 µm. Finally, Kublickiene and colleagues assessed myogenic tone in the absence and presence of NOS inhibition using a parallel experimental design (20) , whereas our experiments were performed in series (e.g., pressure curves are obtained in the absence/presence of inhibitor in each artery studied).
To ensure the myogenic response remained consistent throughout the experiment, we assessed pressures steps from 10mmHg to 60mmHg twice prior to control pressure curve, once at 60 mmHg for the control curve in the absence of the inhibitor, and finally just prior to obtaining the pressure curve in the presence of the inhibitor. We defend our approach on the basis that no difference was observed in MT at 60 mmHg across the four time points in the nonpregnant or pregnant MA (both p=NS).
In light of our observation that MT was attenuated in MA from nonpregnant women 
Perspectives and Significance
Our current understanding of the mechanisms regulating human uteroplacental blood flow in pregnancy remains limited and is primarily derived from various animal models. We and others (19; 39) are now able to obtain and study human arteries from the uterine micro-and macrovasculature. Although endothelial factors such as nitric oxide and prostaglandins contribute to vascular regulation, increasing evidence suggests that downstream cyclic nucleotides are also essential (18; 32; 40; 41) and that various smooth muscle membrane channels (18; 43; 50) are of major importance and need additional study. Furthermore, it is now evident that myogenic responses associated with these pathways may contribute not only to the regulation of total uterine blood flow, but also its redistribution during the course of pregnancy, accounting for the development of a high resistance (myometrium and endometrium) and low resistance vascular bed on the maternal side of the placenta (28; 28-30) . If this is indeed correct, the arteries demonstrating myogenic reactivity might also play an important role in the pathophysiology of preeclampsia and other hypertensive disorders in pregnancy by decreasing perfusion of the maternal placental vascular bed and thus the availability of nutrients required for normal fetal growth and well-being.
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